Trials / Recruiting
RecruitingNCT06546345
Post Market Clinical Follow-Up KeriFlex®
Effectiveness and Safety of the Silicone Joint Implant KeriFlex® and of Its Associated Instruments in the Treatment of MCP and PIP Arthritis: Post Market Clinical Follow up
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 86 (estimated)
- Sponsor
- Keri Medical SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The general objective of this study is to assess the performance and safety of the KeriFlex® silicone joint implant and its associated instruments, used in accordance with the labeling and instructions in force. The performance and safety of the KeriFlex® joint implant will be established in the short and long term with regard to the life cycle of the implant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | KeriFlex® | The KeriFlex® finger joint prothesis MCP is designed to replace a damaged metacarpophalangeal (MCP) joint and the KeriFlex® finger joint prothesis PIP is designed to replace a damaged proximal interphalangeal (PIP) joint. |
Timeline
- Start date
- 2023-11-14
- Primary completion
- 2026-07-01
- Completion
- 2035-01-01
- First posted
- 2024-08-09
- Last updated
- 2025-09-11
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06546345. Inclusion in this directory is not an endorsement.